- Home
- TLSI vs ATLO Comparison
TLSI vs ATLO Comparison
Compare TLSI & ATLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- ATLO
- Stock Information
- Founded
- TLSI 2010
- ATLO 1903
- Country
- TLSI United States
- ATLO United States
- Employees
- TLSI N/A
- ATLO N/A
- Industry
- TLSI Medical Specialities
- ATLO Major Banks
- Sector
- TLSI Health Care
- ATLO Finance
- Exchange
- TLSI Nasdaq
- ATLO Nasdaq
- Market Cap
- TLSI 204.0M
- ATLO 158.4M
- IPO Year
- TLSI N/A
- ATLO N/A
- Fundamental
- Price
- TLSI $5.43
- ATLO $17.70
- Analyst Decision
- TLSI Strong Buy
- ATLO
- Analyst Count
- TLSI 5
- ATLO 0
- Target Price
- TLSI $10.90
- ATLO N/A
- AVG Volume (30 Days)
- TLSI 146.8K
- ATLO 15.9K
- Earning Date
- TLSI 08-13-2025
- ATLO 08-08-2025
- Dividend Yield
- TLSI N/A
- ATLO 4.50%
- EPS Growth
- TLSI N/A
- ATLO 14.69
- EPS
- TLSI N/A
- ATLO 1.27
- Revenue
- TLSI $32,141,000.00
- ATLO $55,041,000.00
- Revenue This Year
- TLSI $55.52
- ATLO N/A
- Revenue Next Year
- TLSI $54.76
- ATLO N/A
- P/E Ratio
- TLSI N/A
- ATLO $13.84
- Revenue Growth
- TLSI 46.20
- ATLO 6.77
- 52 Week Low
- TLSI $3.50
- ATLO $15.69
- 52 Week High
- TLSI $6.04
- ATLO $22.03
- Technical
- Relative Strength Index (RSI)
- TLSI 50.01
- ATLO 49.69
- Support Level
- TLSI $5.18
- ATLO $17.19
- Resistance Level
- TLSI $5.65
- ATLO $17.67
- Average True Range (ATR)
- TLSI 0.35
- ATLO 0.40
- MACD
- TLSI -0.02
- ATLO -0.00
- Stochastic Oscillator
- TLSI 49.23
- ATLO 54.72
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About ATLO Ames National Corporation
Ames National Corporation is a United States-based bank holding company. Through its subsidiaries, it provides checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit of payroll and social security checks, and automated/video teller machine access. Its loan portfolio comprises commercial, residential & agricultural real estate loans; agricultural & business operating loans & lines of credit; equipment loans; vehicle loans; personal loans; and mortgage loans. Its operations are conducted in central, north central, and south-central Iowa.